Addus HomeCare (ADUS) Expected to Announce Earnings on Monday

Addus HomeCare (NASDAQ:ADUS - Get Free Report) is expected to announce its earnings results after the market closes on Monday, February 24th. Analysts expect the company to announce earnings of $1.35 per share and revenue of $291.04 million for the quarter. Individual interested in registering for the company's earnings conference call can do so using this link.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS traded down $1.15 during midday trading on Thursday, reaching $112.07. 162,564 shares of the company's stock traded hands, compared to its average volume of 162,290. The company has a market cap of $2.03 billion, a P/E ratio of 25.65, a PEG ratio of 1.47 and a beta of 1.00. The company has a fifty day simple moving average of $125.55 and a two-hundred day simple moving average of $126.91. Addus HomeCare has a 1 year low of $85.94 and a 1 year high of $136.72.

Insider Transactions at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 2,250 shares of the firm's stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,750 shares of company stock worth $4,930,750 in the last quarter. Company insiders own 4.60% of the company's stock.

Analyst Upgrades and Downgrades

ADUS has been the subject of a number of research reports. JMP Securities initiated coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They set an "outperform" rating and a $150.00 target price for the company. Citizens Jmp upgraded Addus HomeCare to a "strong-buy" rating in a research note on Monday, December 16th. Macquarie restated an "outperform" rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Oppenheimer boosted their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Finally, StockNews.com upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, Addus HomeCare has a consensus rating of "Buy" and an average price target of $134.22.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.